Bio-Rad Hits 52-Week High; Stratagene Leads Index | GenomeWeb
Shares in Bio-Rad Laboratories hit a 52-week high this week, closing Monday at $80.42, up 2.4 percent for the trading period ended Monday — a day earlier than normal due to the Thanksgiving holiday in the US this week. Stratagene led all gainers in the BCW Index with a 7.5 percent jump for the week. Qiagen led decliners for the week with a drop of 4.9 percent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.